Literature DB >> 27003720

Predicted and observed therapeutic dose exceedances of ionizable pharmaceuticals in fish plasma from urban coastal systems.

W Casan Scott1, Bowen Du1, Samuel P Haddad1, Christopher S Breed1, Gavin N Saari1, Martin Kelly2, Linda Broach2, C Kevin Chambliss1,3, Bryan W Brooks1.   

Abstract

Instream flows of the rapidly urbanizing watersheds and estuaries of the Gulf of Mexico in Texas (USA) are increasingly dominated by reclaimed waters. Though ionizable pharmaceuticals have received increasing attention in freshwaters, many research questions remain unanswered, particularly in tidally influenced urban coastal systems, which experience significant spatiotemporal variability in pH that influences bioavailability and bioaccumulation. The authors coupled fish plasma modeling of therapeutic hazard values with field monitoring of water chemistry variability and pharmaceutical occurrence to examine whether therapeutic hazards to fish existed within these urban coastal ecosystems and whether therapeutic hazards differed within and among coastal locations and seasons. Spatial and temporal fluctuations in pH within study sites altered the probability of encountering pharmaceutical hazards to fish. Significant water quality differences were consistently observed among traditional parameters and pharmaceuticals collected from surface and bottom waters, which are rarely sampled during routine surface water quality assessments. The authors then compared modeling predictions of fish plasma concentrations of pharmaceuticals to measured plasma levels from various field-collected fish species. Diphenhydramine and diltiazem were observed in plasma of multiple species, and diltiazem exceeded human therapeutic doses in largemouth bass, catfish, and mullet inhabiting these urban estuaries. Though the present study only examined a small number of target analytes, which represent a microcosm of the exposome of these fish, coastal systems are anticipated to be more strongly influenced by continued urbanization, altered instream flows, and population growth in the future. Unfortunately, aquatic toxicology information for diltiazem and many other pharmaceuticals is not available for marine and estuarine organisms, but such field observations suggest that potential adverse outcomes should be examined.
© 2015 SETAC.

Entities:  

Keywords:  Adverse outcome pathway; Bioaccumulation; Biomonitoring; Fate and transport; Hazard/risk assessment; Municipal effluent; Pharmaceutical; Water quality

Mesh:

Substances:

Year:  2016        PMID: 27003720     DOI: 10.1002/etc.3236

Source DB:  PubMed          Journal:  Environ Toxicol Chem        ISSN: 0730-7268            Impact factor:   3.742


  6 in total

1.  Contaminants of emerging concern in a large temperate estuary.

Authors:  James P Meador; Andrew Yeh; Graham Young; Evan P Gallagher
Journal:  Environ Pollut       Date:  2016-02-21       Impact factor: 8.071

2.  Determining potential adverse effects in marine fish exposed to pharmaceuticals and personal care products with the fish plasma model and whole-body tissue concentrations.

Authors:  James P Meador; Andrew Yeh; Evan P Gallagher
Journal:  Environ Pollut       Date:  2017-07-26       Impact factor: 8.071

3.  Bioaccumulation of pharmaceuticals and personal care product chemicals in fish exposed to wastewater effluent in an urban wetland.

Authors:  Derek Muir; Denina Simmons; Xiaowa Wang; Tom Peart; Maria Villella; Jason Miller; Jim Sherry
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

4.  Reduced anxiety is associated with the accumulation of six serotonin reuptake inhibitors in wastewater treatment effluent exposed goldfish Carassius auratus.

Authors:  D B D Simmons; E S McCallum; S Balshine; B Chandramouli; J Cosgrove; J P Sherry
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

Review 5.  A review of the pharmaceutical exposome in aquatic fauna.

Authors:  Thomas H Miller; Nicolas R Bury; Stewart F Owen; James I MacRae; Leon P Barron
Journal:  Environ Pollut       Date:  2018-04-10       Impact factor: 8.071

6.  Environmental Health Practice Challenges and Research Needs for U.S. Health Departments.

Authors:  Bryan W Brooks; Justin A Gerding; Elizabeth Landeen; Eric Bradley; Timothy Callahan; Stephanie Cushing; Fikru Hailu; Nancy Hall; Timothy Hatch; Sherise Jurries; Martin A Kalis; Kaitlyn R Kelly; Joseph P Laco; Niki Lemin; Carol McInnes; Greg Olsen; Robert Stratman; Carolyn White; Steven Wille; John Sarisky
Journal:  Environ Health Perspect       Date:  2019-12-04       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.